We are live on ! Find out more
Ninety One (UK)

Ninety One (UK) Portfolio holdings

AUM $44.7B
1-Year Est. Return 17.24%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+17.24%
3 Year Est. Return
+87.79%
5 Year Est. Return
+111.34%
10 Year Est. Return
+534.1%
AUM
$18.5B
AUM Growth
+$969M
Cap. Flow
+$640M
Cap. Flow %
3.46%
Top 10 Hldgs %
19.12%
Holding
358
New
39
Increased
130
Reduced
123
Closed
55

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$236M
2
STJ
St Jude Medical
STJ
+$176M
3
MCO icon
Moody's
MCO
+$173M
4
BHC icon
Bausch Health
BHC
+$134M
5
MPC icon
Marathon Petroleum
MPC
+$117M

Sector Composition

Rank Sector Weight
1 Technology 18.72%
2 Healthcare 18.05%
3 Financials 17.97%
4 Communication Services 9.14%
5 Consumer Staples 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMX
51
DELISTED
Terminix Global Holdings, Inc.
TMX
$130M 0.7%
5,154,284
+368,750
+8% +$9.43M
PEG icon
52
Public Service Enterprise Group
PEG
$39.8B
$130M 0.7%
2,750,543
-34,836
-1% -$1.48M
DHR icon
53
Danaher
DHR
$135B
$125M 0.68%
1,965,642
+509,845
+35% +$30.4M
HPE icon
54
Hewlett Packard
HPE
$63.2B
$125M 0.68%
12,155,534
-170,951
-1% -$1.43M
MMM icon
55
3M
MMM
$89B
$125M 0.68%
898,961
+95,480
+12% +$12.3M
AFL icon
56
Aflac
AFL
$63.9B
$119M 0.64%
3,767,084
-44,850
-1% -$1.33M
THO icon
57
Thor Industries
THO
$3.99B
$118M 0.64%
+1,843,870
New +$101M
AVGO icon
58
Broadcom
AVGO
$1.82T
$117M 0.63%
7,587,790
-21,410
-0.3% -$289K
TEVA icon
59
Teva Pharmaceuticals
TEVA
$35.9B
$116M 0.63%
2,171,655
+1,148,997
+112% +$67.4M
AAPL icon
60
Apple
AAPL
$4.89T
$114M 0.62%
4,185,548
-4,079,268
-49% -$102M
PG icon
61
Procter & Gamble
PG
$343B
$114M 0.61%
1,379,844
+528,720
+62% +$42.6M
COR icon
62
Cencora
COR
$60.3B
$113M 0.61%
1,306,091
-853,816
-40% -$76.1M
VTRS icon
63
Viatris
VTRS
$20.1B
$112M 0.6%
2,410,749
-697,179
-22% -$33.7M
DD icon
64
DuPont de Nemours
DD
$18.6B
$110M 0.59%
853,494
+842,734
+7,832% +$101M
MO icon
65
Altria Group
MO
$122B
$107M 0.58%
1,713,845
-81,867
-5% -$4.95M
CE icon
66
Celanese
CE
$5.09B
$105M 0.57%
+1,605,546
New +$99.6M
CAH icon
67
Cardinal Health
CAH
$53.4B
$103M 0.56%
1,257,947
+113,982
+10% +$9.27M
IEX icon
68
IDEX
IEX
$16.5B
$103M 0.56%
1,239,691
-15,118
-1% -$1.13M
GNRC icon
69
Generac Holdings
GNRC
$11.9B
$103M 0.56%
2,758,750
+10,080
+0.4% +$325K
CL icon
70
Colgate-Palmolive
CL
$72.6B
$101M 0.55%
1,431,593
+6,825
+0.5% +$454K
LUV icon
71
Southwest Airlines
LUV
$22B
$100M 0.54%
2,239,649
-28,681
-1% -$1.17M
TFCFA
72
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$95.4M 0.52%
3,422,079
+7,813
+0.2% +$209K
ORCL icon
73
Oracle
ORCL
$331B
$92.6M 0.5%
2,263,310
-66,542
-3% -$2.46M
STI
74
DELISTED
SunTrust Banks, Inc.
STI
$86.7M 0.47%
+2,403,931
New +$86.6M
ALK icon
75
Alaska Air
ALK
$5.15B
$83.2M 0.45%
1,014,421
-1,281,303
-56% -$94.7M

Similar funds

Ninety One (UK)'s Q1 2016 Portfolio in Review

As of Q1 2016, Ninety One (UK) held 358 positions worth $18.5B, up 5.5% from $17.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ninety One (UK) deployed $640M of net new capital in Q1 2016, opening 39 new positions and adding to 130 existing holdings. Its largest new stake was Gilead Sciences: 3,051,840 shares worth $280M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Moody's, an estimated $173M trimmed.

  • Ninety One (UK)'s largest Q1 2016 buy was Gilead Sciences: 3,051,840 shares worth $280M.
  • Ninety One (UK) added most to Alphabet (Google) Class A in Q1 2016, an estimated $218M increase.
  • Ninety One (UK)'s biggest Q1 2016 reduction was Moody's, cutting an estimated $173M.
  • Ninety One (UK) fully exited Goldman Sachs in Q1 2016, selling an estimated $236M.
  • Ninety One (UK)'s ten largest holdings make up 19% of its $18.5B portfolio in Q1 2016.
  • Ninety One (UK) opened 39 new positions and closed 55 in Q1 2016.
  • Ninety One (UK)'s portfolio value rose 5.5% quarter-over-quarter to $18.5B.

Based on Ninety One (UK)'s 13F filing for Q1 2016, filed 12 May 2016.